Target Due Diligence

Target due diligence is a structured evaluation of a company’s technology portfolio, including its patents, publications, and products, conducted to assess the commercial potential and development strength of the target before an acquisition, joint venture, or collaboration decision is made. SciTech Patent Art’s target due diligence service delivers a comprehensive snapshot of what the target has commercialized and what remains in development, giving clients the evidence they need to make informed strategic decisions.

IP due diligence is the process of evaluating the intellectual property assets of a target company to determine their validity, enforceability, commercial relevance, and alignment with the acquiring organization’s strategic objectives before a transaction is completed. SciTech Patent Art conducts IP due diligence across patents, publications, and product portfolios, providing clients with a structured assessment that covers both the strength of individual assets and the overall coherence of the target’s IP strategy.

Patent due diligence examines the specific patents held by a target company to assess their claim quality, legal status, geographic coverage, citation impact, and alignment with the company’s commercial activities and future development roadmap. SciTech Patent Art’s patent due diligence service gives acquirers a precise, evidence-based view of which patents in a target portfolio are genuinely valuable and which carry maintenance costs without proportional strategic or commercial benefit.

Technology due diligence evaluates the full range of a target company’s technological capabilities, including its patented innovations, published research output, and commercially deployed products, to assess the maturity, breadth, and competitive strength of its technology position. SciTech Patent Art’s technology due diligence service is used by acquiring organizations who need to verify that the technology capabilities they are paying for actually exist in the form and at the stage of development the target has represented.

When a transaction’s value depends significantly on the target’s intellectual property, understanding the actual quality, enforceability, and commercial relevance of those IP assets before signing is as important as reviewing the financial statements. SciTech Patent Art’s M&A due diligence IP service covers patent portfolio quality, publication activity, product-to-patent alignment, and legal status review, giving deal teams a complete, documented IP picture before transaction terms are finalized.

Acquisition due diligence for technology companies goes beyond financial and legal review to assess the actual strength and commercial relevance of the target’s patent portfolio, the depth of its technical capabilities, and the degree to which its IP assets are aligned with the products and development programs the acquiring organization wants to access. SciTech Patent Art’s acquisition due diligence service delivers a structured, technology-level assessment that acquisition teams can use directly in valuation discussions and deal negotiations.

Patent portfolio due diligence reviews the full set of patents held by a target company, assessing each asset against criteria including claim quality, legal status, citation impact, geographic coverage, and commercial relevance to produce a prioritized view of the portfolio’s genuine strategic value. SciTech Patent Art’s patent portfolio due diligence service identifies which assets are the portfolio’s most defensible and commercially significant anchors, which are candidates for rationalization, and which represent potential validity risks that could affect the deal’s IP value.

An IP target assessment evaluates a specific company’s intellectual property position ahead of an acquisition, licensing negotiation, or partnership discussion, producing a structured view of the target’s patent quality, publication activity, and technology commercialization track record. SciTech Patent Art’s IP target assessment is designed to give clients a clear, evidence-based answer to whether the target’s IP position supports the strategic and commercial rationale for the transaction being considered.

Technology target evaluation examines how well a target company’s technology portfolio, patent assets, and research outputs align with the acquiring organization’s own development priorities and market objectives, assessing whether the target’s capabilities genuinely complement or extend what the acquirer already has. SciTech Patent Art’s technology target evaluation combines patent analysis, publication review, and product-to-patent mapping to deliver a complete picture of the target’s technology position and its fit with the acquiring organization’s strategic agenda.

Due diligence patent analysis examines the specific patents in a target’s portfolio for claim strength, enforceability, freedom-to-operate implications, and strategic alignment with the acquiring organization’s commercial activities, producing a structured assessment that gives deal teams objective evidence about the IP assets they are acquiring. SciTech Patent Art delivers due diligence patent analysis reports that are structured for direct use by legal teams, corporate development officers, and R&D leaders participating in acquisition evaluation processes.

Target due diligence gives acquiring organizations an evidence-based view of a target’s technology portfolio before deal terms are agreed, ensuring that the value attributed to the target’s IP assets in the transaction reflects their actual quality, enforceability, and commercial relevance rather than face-value patent counts. SciTech Patent Art’s target due diligence service surfaces both the strengths and the vulnerabilities in a target’s IP position, giving acquirers the information they need to negotiate more accurately and avoid post-acquisition surprises.

SciTech Patent Art’s target due diligence assessment covers the target’s patent portfolio quality and legal status, its scientific publication activity and research trajectory, its product commercialization track record, and the alignment between its IP assets and its current and planned commercial activities. Each engagement is structured to answer the core acquisition question directly: whether the target’s technology position is as strong as it appears and whether it supports the strategic rationale the acquiring organization has identified for the transaction.

Acquisitions, joint ventures, joint development programs, and in-licensing transactions where a target company’s technology portfolio is a material component of the deal’s value benefit most from structured target due diligence because the accuracy of the transaction’s IP valuation depends directly on how thoroughly the target’s patent and technology assets have been assessed. SciTech Patent Art has conducted target due diligence engagements across pharmaceuticals, biotechnology, electronics, advanced materials, and specialty chemicals, with domain-specialist analysts who ensure findings are technically precise and commercially relevant for each specific transaction context.

SciTech Patent Art brings over 24 years of patent research and technology analysis experience to every target due diligence engagement, combining deep domain expertise across major technology sectors with proprietary tools for patent quality assessment, publication analysis, and product-to-patent mapping. Clients across corporate development, private equity, and strategic partnerships choose SciTech Patent Art for target due diligence because the depth and accuracy of the IP assessments delivered consistently produce better-informed deal decisions and stronger negotiating positions than less rigorous due diligence approaches provide.